Tenax Therapeutics (TENX) Posts Q2 Loss of 14c/Share

Tenax Therapeutics (NASDAQ: TENX) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Tenax Therapeutics (TENX) PT Raised at Piper Sandler: 'Here's Why Now Is The Time to Own'
• Sharon AI secures six-year compute deal with NVIDIA for Australia deployment
• Aspire Biopharma to acquire automotive supplier for $30 million